In contrast, in vitro studies have shown that some cancer cell lines, such as human breast cancer MCF-7, have lost circadian rhythmicity in clock gene transcription (Xiang et al., 2012), whereas others such as human colon cancer Caco-2 at confluence have retained coordinated circadian expression (Dulong et al., 2015). This evidence concerns the gene CLOCK and cancer.